Acute Myocardial Infarction Management
Immediate Emergency Actions (First 10 Minutes)
For a patient presenting with acute myocardial infarction, immediately administer aspirin 160-325 mg orally, obtain a 12-lead ECG within 10 minutes, establish continuous cardiac monitoring with defibrillation capability, and proceed directly to primary PCI if achievable within 90-120 minutes—otherwise initiate fibrinolytic therapy within 30 minutes of arrival. 1, 2, 3
Critical First Steps
Aspirin 160-325 mg orally (or IV if unable to swallow) without any delay—this is the single most important initial medication 4, 1, 2, 3, 5
12-lead ECG within 10 minutes of arrival to identify ST-segment elevation ≥1 mm in contiguous leads or new left bundle branch block 1, 2, 3
Continuous cardiac monitoring with immediate defibrillator availability to detect life-threatening arrhythmias 1, 2, 3
Oxygen only if SaO₂ <90% or PaO₂ <60 mmHg—routine oxygen is contraindicated when saturation is ≥90% as hyperoxia increases myocardial injury 2, 3
Sublingual nitroglycerin (up to 3 doses, 5 minutes apart) unless systolic BP <90 mmHg or heart rate <50 or >100 bpm 4, 1, 2
Intravenous morphine for pain relief, though be aware this delays oral antiplatelet absorption 4, 2, 6
Reperfusion Strategy Decision (Within 20 Minutes)
The choice between primary PCI and fibrinolytic therapy is time-critical and determines survival:
Primary PCI (Preferred Strategy)
Primary PCI is the reperfusion method of choice when door-to-balloon time can be achieved within 90 minutes of first medical contact (or 120 minutes maximum from STEMI diagnosis). 1, 3
Transfer patient directly to catheterization laboratory, bypassing the emergency department if ST-elevation or new LBBB is present 3
Administer potent P2Y12 inhibitor (prasugrel or ticagrelor preferred over clopidogrel) before or at time of PCI 3, 5
High-risk patients (anterior MI, shock, pulmonary congestion, heart rate >100 bpm, systolic BP <100 mmHg) should be triaged directly to PCI-capable facilities 1
Fibrinolytic Therapy (When PCI Delayed)
If primary PCI cannot be performed within 120 minutes of STEMI diagnosis, initiate fibrinolytic therapy immediately with door-to-needle time ≤30 minutes. 1, 3
Greatest benefit occurs within first 6 hours of symptom onset (35 lives saved per 1,000 patients treated within first hour vs. 16 lives saved per 1,000 patients treated at 7-12 hours) 1
Reperfusion therapy beyond 12 hours offers minimal benefit in most patients 1
After fibrinolysis, avoid catheterization within 2-3 hours due to increased bleeding risk, but perform angiography within 24 hours 1
Additional Immediate Pharmacotherapy
Beta-Blockers
Intravenous beta-blocker should be administered early, followed by oral therapy for at least 6 weeks, unless contraindications exist (heart failure signs, low-output state, increased cardiogenic shock risk) 4, 2
Beta-blockers reduce both morbidity and mortality regardless of whether reperfusion therapy was given 4
Anticoagulation
Unfractionated heparin IV for 48 hours if receiving alteplase 4
High-dose IV heparin when performing primary PTCA 4
Continue anticoagulation until revascularization or for duration of hospital stay up to 8 days 3
Fondaparinux is contraindicated for primary PCI 3
Nitroglycerin
Intravenous nitroglycerin for 24-48 hours after hospitalization, titrated to blood pressure and heart rate 4
Critical caveat: Avoid nitrates in inferior STEMI with suspected right ventricular involvement—can cause profound hypotension 2
Magnesium
- Magnesium sulfate to replete deficits for 24 hours 4
Management of Complications During Hospitalization
Recurrent Chest Pain
If pericarditis: High-dose aspirin 650 mg every 4-6 hours 4
If recurrent ischemia: IV nitroglycerin, analgesics, antithrombotic medications (aspirin, heparin), and consider urgent coronary angiography with revascularization 4
Heart Failure
Diuretic (usually IV furosemide) and afterload-reducing agent 4
ACE inhibitor within 24 hours in patients with heart failure, LV systolic dysfunction, diabetes, or anterior infarct 3
Cardiogenic Shock
- Intra-aortic balloon pump and emergency coronary angiography followed by PTCA or CABG 4
Right Ventricular Infarction
Vigorous intravascular volume expansion with normal saline and inotropic agents if hypotension persists 4
Avoid excessive fluid in patients without RV involvement as it worsens LV failure 2
Bradyarrhythmias
Atropine 0.5-1.0 mg IV for symptomatic or hemodynamically significant bradycardia (may repeat to maximum 3 mg) 2, 3
Pre-Discharge Assessment (4-14 Days)
Exercise testing: Submaximal at 4-7 days or symptom-limited at 10-14 days to assess functional capacity, evaluate medical regimen efficacy, and stratify risk 4
Routine echocardiography to assess LV and RV function, detect mechanical complications, and exclude LV thrombus 3
Long-Term Management (Indefinite Duration)
All post-MI patients should receive indefinite aspirin 75-100 mg daily, beta-blocker, ACE inhibitor, and high-intensity statin therapy. 4, 3
Dual Antiplatelet Therapy
- Aspirin plus ticagrelor or prasugrel (or clopidogrel if unavailable/contraindicated) for 12 months after PCI unless excessive bleeding risk 3, 5
Lipid Management
High-intensity statin started as early as possible 3
If LDL >130 mg/dL despite diet, intensify drug therapy with goal LDL <100 mg/dL 4
Lifestyle Modifications
Smoking cessation is essential 4
Diet low in saturated fat and cholesterol 4
Achieve ideal body weight 4
Exercise 20 minutes at brisk walking level at least 3 times weekly 4
Formal cardiac rehabilitation program participation 4
Critical Pitfalls to Avoid
Never delay reperfusion waiting for cardiac biomarkers when ECG shows ST-elevation or new LBBB—ECG findings alone warrant immediate treatment 1, 2
Never send patient to physician's office—transport directly to hospital with 24-hour emergency cardiac care capability 1
Never withhold treatment for insurance authorization or administrative procedures 2
Never perform routine catheterization within 2-3 hours of fibrinolytic administration unless rescue PCI is needed for failed reperfusion 1
Never use calcium channel blockers routinely—they have not reduced mortality and may be harmful in certain patients 4
Never give routine oxygen when SaO₂ ≥90%—this causes harm through increased myocardial injury 2, 3